You are here

  • Home
  • Archive
  • Volume 65, Issue 7
  • Cross-immunogenicity: antibodies to infliximab in Remicade-treated patients with IBD similarly recognise the biosimilar Remsima

Article metrics

Article menu
Download PDFPDF
Inflammatory bowel disease
Original article
Cross-immunogenicity: antibodies to infliximab in Remicade-treated patients with IBD similarly recognise the biosimilar Remsima

 

Online download statistics by month:

Online download statistics by month: April 2015 to March 2024

AbstractFullPdf
Apr 2015145266138
May 201550886140
Jun 20152666682
Jul 20152123548
Aug 20152303135
Sep 20151833033
Oct 20151312730
Nov 20152214247
Dec 20151553139
Jan 20161944343
Feb 20161301926
Mar 20161623143
Apr 20161863545
May 20161923236
Jun 2016146871171
Jul 20166234388
Aug 20163833056
Sep 20162204050
Oct 20162403043
Nov 20162072334
Dec 20161701624
Jan 20171534345
Feb 20171132211
Mar 20171603621
Apr 20171293420
May 20172782011
Jun 20171133924
Jul 20172542221
Aug 20172232912
Sep 2017270229
Oct 20172151512
Nov 20172652513
Dec 20171442214
Jan 20182081612
Feb 2018172169
Mar 20181512310
Apr 20182012114
May 2018215137
Jun 20181952816
Jul 2018196189
Aug 2018134124
Sep 2018168147
Oct 2018147147
Nov 20181641513
Dec 2018250106
Jan 20191621516
Feb 201914268
Mar 20191461011
Apr 2019179128
May 20191531119
Jun 20198765
Jul 20199694
Aug 201913754
Sep 20192011017
Oct 201913345
Nov 20191291216
Dec 2019154710
Jan 202016764
Feb 202015496
Mar 202012146
Apr 202010796
May 202012823
Jun 202013082
Jul 202012357
Aug 20207852
Sep 20201281511
Oct 20209495
Nov 202013863
Dec 20206920
Jan 202113385
Feb 20211381013
Mar 20219852
Apr 202111456
May 20212443
Jun 2021541
Jul 20211178
Aug 2021982
Sep 2021423
Oct 2021113145
Nov 202111573
Dec 20217960
Jan 2022108120
Feb 20229762
Mar 202211643
Apr 202212694
May 202213042
Jun 202216872
Jul 202211363
Aug 202212631
Sep 202219295
Oct 202217460
Nov 202219823
Dec 202219030
Jan 20239872
Feb 202321965
Mar 202318444
Apr 202312361
May 202317353
Jun 20237933
Jul 202315684
Aug 202316620
Sep 202326441
Oct 202315020
Nov 202311950
Dec 202321851
Jan 202415235
Feb 2024175417
Mar 202420152
Total2026517631880